These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35332774)

  • 1. Discovery of MK-1454: A Potent Cyclic Dinucleotide Stimulator of Interferon Genes Agonist for the Treatment of Cancer.
    Chang W; Altman MD; Lesburg CA; Perera SA; Piesvaux JA; Schroeder GK; Wyss DF; Cemerski S; Chen Y; DiNunzio E; Haidle AM; Ho T; Kariv I; Knemeyer I; Kopinja JE; Lacey BM; Laskey J; Lim J; Long BJ; Ma Y; Maddess ML; Pan BS; Presland JP; Spooner E; Steinhuebel D; Truong Q; Zhang Z; Fu J; Addona GH; Northrup AB; Parmee E; Tata JR; Bennett DJ; Cumming JN; Siu T; Trotter BW
    J Med Chem; 2022 Apr; 65(7):5675-5689. PubMed ID: 35332774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STimulator of INterferon Genes Agonism Accelerates Antitumor Activity in Poorly Immunogenic Tumors.
    Perera SA; Kopinja JE; Ma Y; Muise ES; Laskey J; Chakravarthy K; Chen Y; Cui L; Presland J; Sathe M; Javaid S; Minnihan EC; Ferguson HM; Piesvaux J; Pan BS; Zhao S; Sharma SK; Woo HC; Pucci V; Knemeyer I; Cemerski S; Cumming J; Trotter BW; Tse A; Khilnani A; Ranganath S; Long BJ; Bennett DJ; Addona GH
    Mol Cancer Ther; 2022 Feb; 21(2):282-293. PubMed ID: 34815361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of BI 7446: A Potent Cyclic Dinucleotide STING Agonist with Broad-Spectrum Variant Activity for the Treatment of Cancer.
    Kuttruff CA; Fleck M; Carotta S; Arnhof H; Bretschneider T; Dahmann G; Gremel G; Grube A; Handschuh S; Heimann A; Hofmann MH; Impagnatiello MA; Nar H; Rast G; Schaaf O; Schmidt E; Oost T
    J Med Chem; 2023 Jul; 66(14):9376-9400. PubMed ID: 37450324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of Potent Immune Modulators Targeting Stimulator of Interferon Genes Receptor.
    Jeon MJ; Lee H; Lee J; Baek SY; Lee D; Jo S; Lee JY; Kang M; Jung HR; Han SB; Kim NJ; Lee S; Kim H
    J Med Chem; 2022 Apr; 65(7):5407-5432. PubMed ID: 35315650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of Non-Nucleotide Small-Molecule STING Agonists
    Cherney EC; Zhang L; Lo J; Huynh T; Wei D; Ahuja V; Quesnelle C; Schieven GL; Futran A; Locke GA; Lin Z; Monereau L; Chaudhry C; Blum J; Li S; Fereshteh M; Li-Wang B; Gangwar S; Pan C; Chong C; Zhu X; Posy SL; Sack JS; Zhang P; Ruzanov M; Harner M; Akhtar F; Schroeder GM; Vite G; Fink B
    J Med Chem; 2022 Feb; 65(4):3518-3538. PubMed ID: 35108011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of novel amidobenzimidazole derivatives as orally available small molecule modulators of stimulator of interferon genes for cancer immunotherapy.
    Jeon MJ; Lee H; Jo S; Kang M; Jeong JH; Jeong SH; Lee JY; Song GY; Choo H; Lee S; Kim H
    Eur J Med Chem; 2023 Dec; 261():115834. PubMed ID: 37862818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SHR1032, a novel STING agonist, stimulates anti-tumor immunity and directly induces AML apoptosis.
    Song C; Liu D; Liu S; Li D; Horecny I; Zhang X; Li P; Chen L; Miller M; Chowdhury R; Issa M; Shen R; Yan Y; Zhang F; Zhang L; Zhang L; Bai C; Feng J; Zhuang L; Zhang R; Li J; Wilkinson H; Liu J; Tao W
    Sci Rep; 2022 May; 12(1):8579. PubMed ID: 35595822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting interferon signaling and CTLA-4 enhance the therapeutic efficacy of anti-PD-1 immunotherapy in preclinical model of HPV
    Dorta-Estremera S; Hegde VL; Slay RB; Sun R; Yanamandra AV; Nicholas C; Nookala S; Sierra G; Curran MA; Sastry KJ
    J Immunother Cancer; 2019 Sep; 7(1):252. PubMed ID: 31533840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. M335, a novel small-molecule STING agonist activates the immune response and exerts antitumor effects.
    Zhao M; Fan W; Wang Y; Qiang P; Zheng Z; Shan H; Zhang M; Liu P; Wang Y; Li G; Li M; Hong L
    Eur J Med Chem; 2024 Jan; 264():116018. PubMed ID: 38091891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of Orally Bioavailable Amidobenzimidazole Analogues Targeting Stimulator of Interferon Gene (STING) Receptor.
    Chen NN; Zhang H; Zhu QS; Zeng T; Dai W; Zhou YL; Xin GF; Wu BD; Gong SJ; Jiang ZY; You QD; Xu XL
    J Med Chem; 2023 Apr; 66(8):5584-5610. PubMed ID: 37027512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor Regression upon Intratumoral and Subcutaneous Dosing of the STING Agonist ALG-031048 in Mouse Efficacy Models.
    Jekle A; Thatikonda SK; Jaisinghani R; Ren S; Kinkade A; Stevens SK; Stoycheva A; Rajwanshi VK; Williams C; Deval J; Mukherjee S; Zhang Q; Chanda S; Smith DB; Blatt LM; Symons JA; Gonzalvez F; Beigelman L
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Novel Carbocyclic Pyrimidine Cyclic Dinucleotide STING Agonists for Antitumor Immunotherapy Using Systemic Intravenous Route.
    Vyskocil S; Cardin D; Ciavarri J; Conlon J; Cullis C; England D; Gershman R; Gigstad K; Gipson K; Gould A; Greenspan P; Griffin R; Gulavita N; Harrison S; Hu Z; Hu Y; Hata A; Huang J; Huang SC; Janowick D; Jones M; Kolev V; Langston SP; Lee HM; Li G; Lok D; Ma L; Mai D; Malley J; Matsuda A; Mizutani H; Mizutani M; Molchanova N; Nunes E; Pusalkar S; Renou C; Rowland S; Sato Y; Shaw M; Shen L; Shi Z; Skene R; Soucy F; Stroud S; Xu H; Xu T; Abu-Yousif AO; Zhang J
    J Med Chem; 2021 May; 64(10):6902-6923. PubMed ID: 34000802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STING activation normalizes the intraperitoneal vascular-immune microenvironment and suppresses peritoneal carcinomatosis of colon cancer.
    Lee SJ; Yang H; Kim WR; Lee YS; Lee WS; Kong SJ; Lee HJ; Kim JH; Cheon J; Kang B; Chon HJ; Kim C
    J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34145029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-Activity relationship study of benzothiophene oxobutanoic acid analogues leading to novel stimulator of interferon gene (STING) agonists.
    Shen A; Li X; Zhang Y; Ma J; Xiao R; Wang X; Song Z; Liu Z; Geng M; Zhang A; Xie Z; Ding C
    Eur J Med Chem; 2022 Nov; 241():114627. PubMed ID: 35963129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agonist of stimulator of interferon genes as antitumor agents: a patent review (2008-2020).
    Chen NN; Zhang H; You QD; Xu XL
    Expert Opin Ther Pat; 2021 Jun; 31(6):563-584. PubMed ID: 33459063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biodegradable STING agonist nanoparticles for enhanced cancer immunotherapy.
    Wilson DR; Sen R; Sunshine JC; Pardoll DM; Green JJ; Kim YJ
    Nanomedicine; 2018 Feb; 14(2):237-246. PubMed ID: 29127039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STING agonist loaded lipid nanoparticles overcome anti-PD-1 resistance in melanoma lung metastasis via NK cell activation.
    Nakamura T; Sato T; Endo R; Sasaki S; Takahashi N; Sato Y; Hyodo M; Hayakawa Y; Harashima H
    J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34215690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STING agonist and IDO inhibitor combination therapy inhibits tumor progression in murine models of colorectal cancer.
    Shi J; Liu C; Luo S; Cao T; Lin B; Zhou M; Zhang X; Wang S; Zheng T; Li X
    Cell Immunol; 2021 Aug; 366():104384. PubMed ID: 34182334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E7766, a Macrocycle-Bridged Stimulator of Interferon Genes (STING) Agonist with Potent Pan-Genotypic Activity.
    Kim DS; Endo A; Fang FG; Huang KC; Bao X; Choi HW; Majumder U; Shen YY; Mathieu S; Zhu X; Sanders K; Noland T; Hao MH; Chen Y; Wang JY; Yasui S; TenDyke K; Wu J; Ingersoll C; Loiacono KA; Hutz JE; Sarwar N
    ChemMedChem; 2021 Jun; 16(11):1740-1743. PubMed ID: 33522135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, Synthesis, and Biological Evaluation of Amidobenzimidazole Derivatives as Stimulator of Interferon Genes (STING) Receptor Agonists.
    Xi Q; Wang M; Jia W; Yang M; Hu J; Jin J; Chen X; Yin D; Wang X
    J Med Chem; 2020 Jan; 63(1):260-282. PubMed ID: 31820985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.